TRCT
ICU icon

Tower Research Capital (TRC)’s SeaStar Medical ICU Stock Holding History

Tower Research Capital (TRC)’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98K Sell
1,356
-39
-3% -$148 ﹤0.01% 4323
2026
Q1 		$5.19K Buy
+1,395
New +$3.52K ﹤0.01% 4134
2025
Q4 		– Sell
-13
Closed -$75 – 5350
2025
Q3 		$75 Sell
13
-532
-98% -$4.1K ﹤0.01% 5128
2025
Q2 		$2.32K Buy
545
+355
+187% +$4.09K ﹤0.01% 4666
2025
Q1 		$3.15K Sell
190
-154
-45% -$2.9K ﹤0.01% 4462
2024
Q4 		$6.66K Buy
344
+257
+295% +$7.34K ﹤0.01% 4155
2024
Q3 		$3.72K Buy
87
+23
+36% +$1.54K ﹤0.01% 4785
2024
Q2 		$4.86K Buy
64
+54
+540% +$5.79K ﹤0.01% 4739
2024
Q1 		$1.82K Sell
10
-31
-76% -$6.08K ﹤0.01% 5177
2023
Q4 		$4.56K Buy
41
+1
+3% +$148 ﹤0.01% 4940
2023
Q3 		$2.63K Hold
40
– – ﹤0.01% 5127
2023
Q2 		$5.16K Buy
40
+21
+111% +$6.28K ﹤0.01% 4855
2023
Q1 		$9K Buy
19
+16
+533% +$13.6K ﹤0.01% 4497
2022
Q4 		$3K Sell
3
-1
-25% -$1.62K ﹤0.01% 5194
2022
Q3 		$10K Hold
4
– – ﹤0.01% 4539
2022
Q2 		$10K Hold
4
– – ﹤0.01% 4452
2022
Q1 		$10K Buy
+4
New +$10.1K ﹤0.01% 4308

Other funds holding ICU

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Tower Research Capital (TRC)'s ICU Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its SeaStar Medical (ICU) stake by 2.8% in Q2 2026, selling an estimated $148 and leaving 1,356 shares worth $4.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4323.

Tower Research Capital (TRC) first reported a position in ICU in Q1 2022 and has held it in 17 quarters since. The position peaked at $10K in Q3 2022. 18 funds tracked by Wall St. Rank hold ICU as of Q2 2026.

  • Tower Research Capital (TRC) held 1,356 shares of SeaStar Medical worth $4.98K as of Q2 2026.
  • Tower Research Capital (TRC) sold 39 SeaStar Medical shares in Q2 2026, an estimated $148.
  • SeaStar Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4323 holding.
  • Tower Research Capital (TRC) first reported a position in SeaStar Medical in Q1 2022 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s SeaStar Medical position peaked at $10K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.